TG-100435

SKU: orb2814819

Description

TG-100435 is an investigational oral multi-target tyrosine kinase inhibitor. Its metabolic processing is suppressed by methimazole and ketoconazole, with cytochrome P450 reductase implicated in its formation. This compound is utilized in preclinical research to study kinase signaling pathways in cancer and other diseases, both in cellular and animal models.

Research Area

Cardiovascular Research, Signal Transduction

Key Properties

• CAS Number: 867330-68-5
• MW: 494.42
• Formula: C₂₆H₂₅Cl₂N₅O
• SMILES: ClC=1C=CC=C(Cl)C1C2=CC=3N=NC(=NC3C(=C2)C)NC4=CC=C(OCCN5CCCC5)C=C4
• Target: Src,Bcr-Abl,Ephrin Receptor

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

11562302